Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
67 JPY
1.42 B JPY
17.74 B JPY
3.02 M
About I'ROM GROUP CO LTD
Sector
Industry
Headquarters
Tokyo
Website
Founded
1997
ISIN
JP3105170009
FIGI
BBG000Q0VW41
I'rom Group Co., Ltd. engages in the medical support business. It operates through five reportable segments: Advanced Medical Business, Site Management Organization (SMO) Business, Contract Research Organization (CRO) Business, Drug Discovery Business and Medical Support Business. Advanced Medical Business is that applies superior vector technology to develop vaccines and gene therapy preparations, and develops, manufactures and sells products in the field of regenerative medicine. SMO Business are commissioned by medical institutions to carry out some of the work related to the implementation of clinical trials, and act on their behalf and provide support. CRO Business involves accepting all or part of the work related to clinical trials from pharmaceutical companies and other entities and acting on their behalf and providing support. Drug Discovery Business involves the joint development of important, highly effective pharmaceuticals, such as biosimilars, based on license agreements and other agreements with pharmaceutical companies, both domestic and overseas. Medical Support Business is a business that provides general and comprehensive support for medical practice management, including the establishment and rental of clinic malls, product sales, and other related services. The company was founded on April 9, 1997 and is headquartered in Tokyo, Japan.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 2372 is 2,786 JPY — it hasn't changed in the past 24 hours. Watch I'ROM GROUP CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange I'ROM GROUP CO LTD stocks are traded under the ticker 2372.
2372 stock hasn't changed in a week, the month change is a −0.32% fall, over the last year I'ROM GROUP CO LTD has showed a 46.63% increase.
2372 reached its all-time high on Mar 2, 2005 with the price of 18,800 JPY, and its all-time low was 148 JPY and was reached on Nov 2, 2010. View more price dynamics on 2372 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2372 stock is 0.04% volatile and has beta coefficient of 0.07. Track I'ROM GROUP CO LTD stock price on the chart and check out the list of the most volatile stocks — is I'ROM GROUP CO LTD there?
Today I'ROM GROUP CO LTD has the market capitalization of 33.73 B, it has increased by 0.04% over the last week.
Yes, you can track I'ROM GROUP CO LTD financials in yearly and quarterly reports right on TradingView.
I'ROM GROUP CO LTD is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
2372 net income for the last quarter is 430.00 M JPY, while the quarter before that showed −356.00 M JPY of net income which accounts for 220.79% change. Track more I'ROM GROUP CO LTD financial stats to get the full picture.
I'ROM GROUP CO LTD dividend yield was 2.12% in 2023, and payout ratio reached 34.23%. The year before the numbers were 2.64% and 23.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 1, 2025, the company has 1.03 K employees. See our rating of the largest employees — is I'ROM GROUP CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. I'ROM GROUP CO LTD EBITDA is 2.29 B JPY, and current EBITDA margin is 12.80%. See more stats in I'ROM GROUP CO LTD financial statements.
Like other stocks, 2372 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade I'ROM GROUP CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So I'ROM GROUP CO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating I'ROM GROUP CO LTD stock shows the buy signal. See more of I'ROM GROUP CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.